Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin

Arnt, 1985, Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in rescrpine-pretreated but not normal rats, Eur. J. Pharmacol., 113, 79, 10.1016/0014-2999(85)90345-0 Arnt, 1984, Differential inhibition by dopamine D-l and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions, Eur. J. Pharmacol., 102, 349, 10.1016/0014-2999(84)90267-X Beckstead, 1979, Efferent connections of the substantia nigra and ventral tegmental area in the rat, Brain Res., 175, 191, 10.1016/0006-8993(79)91001-1 Civelli, 1993, Molecular diversity of the dopamine receptors, Annu. Rev. Pharmacol. Toxicol., 32, 281, 10.1146/annurev.pa.33.040193.001433 Cornish, 1994, Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system, Neurosci. Lett., 176, 142, 10.1016/0304-3940(94)90068-X Eison, 1982, Substance P analogue, DiMe-C7: evidence for stability in rat brain and prolonged central actions, Science, 215, 188, 10.1126/science.6171884 Elliot, 1982, Substance P and its analogue. DiMe-C7: effects on behaviour, Neurosci. Lett., 31, 5163 Elliot, 1986, Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area, Brain Res., 363, 145, 10.1016/0006-8993(86)90667-0 Freedman, 1994, Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat, Brain Res., 633, 243, 10.1016/0006-8993(94)91545-8 Gray, 1989, Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release, Neuroendocrinology, 50, 433, 10.1159/000125260 Hall, 1988, Raclopride, a new selective ligand for the dopamine-D2 receptors, Progr. Neuro-Psychopharmacol. Biol. Psych., 12, 559, 10.1016/0278-5846(88)90001-2 Harris, 1990, Neural regulation of vasopressincontaining hypothalamic neurons and the role of vasopressin in cardiovascular function, 224 Hayward, 1977, Temporal patterns of vasopressin release following electrical stimulation of the amygdala and the neuroen docrine pathway in the monkey, Neuroendocrinology, 23, 61, 10.1159/000122655 Iorio, 1983, SCH23390, a potential benzazepine antipsychotic with unique interactions of dopaminergic systems, J. Pharmacol. Exp. Ther., 226, 462 Kalivas, 1993, Neurotransmitter regulation of dopamine neurons in the ventral tegmental area, Brain Res. Rev., 18, 75, 10.1016/0165-0173(93)90008-N Kilts, 1988, The biochemistry and pharmacology of mesoamygdaloid dopamine neurons, Ann. New York Acad. Sci., 537, 173, 10.1111/j.1749-6632.1988.tb42105.x Lin, 1994, Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats, Am. J. Physiol., 266, H2489 Nagahama, 1986, Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat, J. Pharmacol. Exp. Ther., 236, 735 Oades, 1987, Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity, Brain Res. Rev., 12, 117, 10.1016/0165-0173(87)90011-7 Overton, 1992, Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat, Eur. J. Pharmacol., 213, 165, 10.1016/0014-2999(92)90251-X Paxinos, 1982 Pittman, 1981, Connections of the hypothalamic paraventricular nucleus with the neurohypophysis, median eminence, amygdala, lateral septum and midbrain periaquaduc tal gray: an electrophysiological study in the rat, Brain Res., 215, 15, 10.1016/0006-8993(81)90488-1 Sandberg, 1981, Synthesis and biological properties of enzyme-resistant analogues of substance P, Eur. J. Biochem., 114, 329, 10.1111/j.1432-1033.1981.tb05152.x Sawchenko, 1983, The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat, J. Comp. Neurol., 218, 121, 10.1002/cne.902180202 Seeman, 1994, Dopamine receptor pharmacology, Trends Pharmacol. Sci., 15, 264, 10.1016/0165-6147(94)90323-9 Shults, 1984, A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system, Peptides, 5, 1097, 10.1016/0196-9781(84)90177-3 Sklar, 1983, Central nervous system mediators of vasopressin release, Physiol. Rev., 63, 1243, 10.1152/physrev.1983.63.4.1243 Spring, 1975, Ventral midbrain stimulation, blood pressure responses and their relation to the dopaminergic nigro-striatal pathways, Pflugers Arch., 358, 339, 10.1007/BF00580531 Stoessl, 1990, Autoradiographic visualisation of NK-3 tachykinin binding sites in the rat brain, utilising 3H]senktide, Brain Res., 534, 1, 10.1016/0006-8993(90)90105-K Stoessl, 1991, Behavioural effects of selective tachykinin agonists in midbrain dopamine regions, Brain Res., 565, 254, 10.1016/0006-8993(91)91657-M Swanson, 1982, The projections of the ventral tegmental area and adjacent regions: a combined flourescent retrograde tracer and immunoflourescence study in the rat, Brain Res. Bull., 9, 321, 10.1016/0361-9230(82)90145-9 Tan, 1983, Intense vasoconstriction and bradycardia evoked by stimulation of neurones within the midbrain and the ventral tegmentum of the rabbit, Clin. Exp. Pharmacol. Physiol., 10, 305, 10.1111/j.1440-1681.1983.tb00202.x Undesser, 1985, Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits, Circ. Res., 56, 410, 10.1161/01.RES.56.3.410 Unger, 1981, Central blood pressure effects of substance P and angiotensin 11: role of the sympathetic nervous system and vasopressin, Eur. J. Pharmacol., 71, 33, 10.1016/0014-2999(81)90384-8 Ungerstedt, 1971, Stercotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol. Scand., 197, 1, 10.1111/j.1365-201X.1971.tb10998.x Van den Buuse, 1992, Central effects of quinpirole on blood pressure of spontaneously hypertensive rats, J. Pharmacol. Exp. Ther., 262, 303 Van den Buuse, 1989, Differential effects of dopaminergic drugs on openfield behaviour of spontaneously hypertensive rats and normotensive wistar-Kyoto rats, J. Pharmacol. Exp. Ther., 248, 1189 Van den Buuse, 1992, Pharmacology of central dopaminergic modulation in hypertension, Vol. 2, 157 Van den Buuse, 1992, Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats, Brain Res. Bull., 28, 289, 10.1016/0361-9230(92)90190-9 Van den Buuse, 1991, Role of brain dopamine systems in the development of hypertension in the spontaneously hypertensive rat, Clin. Exp. Hypert., A13, 653 Van den Buuse, 1986, Substantia nigra lesions attenuate the development of hypertension and behavioural hyperreactivity in spontaneously hypertensive rats, Pharmacol. Biochem. Behav., 25, 317, 10.1016/0091-3057(86)90002-X Waddington, 1989, Functional interactions between D-I and D dopamine receptor systems: their role in the regulation of psychomotor behaviour, putative mechanisms, and clinical relevance, J. Psychopharmacol., 3, 54, 10.1177/026988118900300202 Walters, 1987, D-1 dopamine receptor activation required for postsynaptic expression of D-2 agonist effects, Science, 236, 719, 10.1126/science.2953072 Yang, 1990, Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555), Brain Res. Bull., 24, 97, 10.1016/0361-9230(90)90292-8